![Robert Corringham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Corringham
Plus aucun poste en cours
Profil
Robert Corringham served as President of Centocor, Inc. and held senior positions at Ambit Biosciences Corp.
and Bionomics Ltd. He was also a Professor at the University of Toronto and the University of California San Diego.
Additionally, he was a Director at GlaxoSmithKline Australia Pty Ltd. and the University of California, Davis.
He served as Vice President-Clinical Development at Astex Pharmaceuticals, Inc. and Chief Medical Officer at Triphase Accelerator Corp.
Corringham earned a doctorate degree from the University of London.
Anciens postes connus de Robert Corringham
| Sociétés | Poste | Fin |
|---|---|---|
Astex Pharmaceuticals, Inc.
 Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Directeur Technique/Scientifique/R&D | 01/05/2012 |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
University of Toronto
 University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Triphase Accelerator Corp.
 Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Directeur Technique/Scientifique/R&D | - |
Glaxosmithkline Australia Pty Ltd.
 Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, vaccines and consumer healthcare products | Directeur/Membre du Conseil | - |
Formation de Robert Corringham
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Manufactures healthcare products | Health Technology |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Develops and sells molecule kinase inhibitors for the treatment of cancer | Health Technology |
Bionomics Ltd.
 Bionomics Ltd. Pharmaceuticals: GenericHealth Technology Develops drug for treatment of central nervous system disorders | Health Technology |
University of London
 University of London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Toronto
University of Toronto Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Ottawa Heart Institute
 The University of Ottawa Heart Institute Hospital/Nursing ManagementHealth Services Operates cardiac surgical hospitals | Health Services |
Princess Margaret Hospital
 Princess Margaret Hospital Part of Royal Group (United Arab Emirates), Princess Margaret Hospital Dental oncology is a company that specializes in dental oncological and maxillofacial prosthetics, with a focus on head and neck cancer, chemotherapy, malignant hematology, osteonecrosis/MRONJ, and medication-related osteoradionecrosis of the jaw (MRONj). Princess Margaret Hospital offers palliative care and have a High-Risk Oral Lesion Clinic. The clinic is staffed by a team of full-time dentists, clinical associates, clinical fellows, consultants, and support staff. The company is based in Toronto, Canada. The company was founded by David Alexander MacNicol. The CEO is Cho-Ze Joseph Lui. | |
Astex Pharmaceuticals, Inc.
Astex Pharmaceuticals, Inc. BiotechnologyHealth Technology Researches and develops drugs for oncology & CNS disorders | Health Technology |
Glaxosmithkline Australia Pty Ltd.
Glaxosmithkline Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceuticals, vaccines and consumer healthcare products | Health Technology |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Operates as a drug development company that manufactures oncology therapeutics for the treatment of cancer | Health Technology |
Choisissez Zonebourse 
